Movement Disorders
The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA,
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA,
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD
By David Choon Liang Teo, MBBS, MRC Psych (UK), FAMS
Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome
Welcome to the Neuroscience Report where each week we will
Welcome to the Neuroscience Report where each week we will
by Jason Yanofski, MD From the Forensic Psychiatry Department, Yale
Parikshit Deshmukh, MD; Guarav Kulkarni, MD; and Drew Barzman, MD
by Brendan T. Carroll, MD, and Susan A. Surber, Pharm.d